Aeovian Pharmaceuticals
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2930 Domingo Ave Pmb 145, Berkeley, Cali...Phone Number
(510) 961-1148Website
www.aeovian.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Aeovian Pharmaceuticals
AEovian is a research stage biopharmaceutical company that develops novel therapeutics modulating mTORC1 pathway. The company was founded in 2012 and is headquartered in San Francisco, California.Explore more
Aeovian Pharmaceuticals Org Chart
DR
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aeovian Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aeovian Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Aeovian Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Aeovian Pharmaceuticals has new funding data
Earning: See what the market has to say on Aeovian Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aeovian Pharmaceuticals
Check if Aeovian Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Aeovian Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Aeovian Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Aeovian Pharmaceuticals
Compare insights from companies similar to Aeovian Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Aeovian Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aeovian Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aeovian Pharmaceuticals.
Aeovian Pharmaceuticals financials insights
Gather financial insights about Aeovian Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$37M
2024
Debt
$50M
2025
Series B
$55M
Aeovian Pharmaceuticals Tech Stack
A closer look at the technologies used by Aeovian Pharmaceuticals
Most Recent Scoops
Funding
Funding
Funding
Funding
Executive Move
Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Board of Directors
Aeovian Pharmaceuticals News & Media
Aeovian Pharma raises $55M to advance epilepsy candidate | The Pharmaletter
California, USA-based clinical-stage biopharmaceutical company Aeovian Pharmaceuticals revealed it has closed an oversubscribed $55 million Series B financing that will fund completion of a Phase II proof-of-concept study for its lead development candidate, AV078, in tuberous sclerosis complex (TSC)-related refractory epilepsy.TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex
SILVER SPRING, Md., Dec. 16, 2025 /PRNewswire/ -- The TSC Alliance Endowment Fund, a supporting organization of the TSC Alliance, has invested in Aeovian Pharmaceuticals as part of their Series B financing in support of their Phase 2 trial of AV078, a first-in-class CNS-penetrant...AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING
First Cohort of Participants Dosed in Phase 1 Clinical Trial with Lead Development Candidate AV078 Intended for the Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) Leadership Team Strengthened with the Appointment of William Greene, MD, CIO at Hevolution, and Justin...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aeovian Pharmaceuticals
Sign Up For FreeTo access detailed company insights
AEovian is a research stage biopharmaceutical company that develops novel therapeutics modulating mTORC1 pathway. The company was founded in 2012 and is headquartered in San Francisco, California.... Read More
